Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity

Lupus

Volumn 22, Issue 8, 2013, Pages 827-834

  Stojan, G ^a   Fang, H ^a   Magder, L ^b   Petri, M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

disease activity; Erythrocyte sedimentation rate; ESR; systemic lupus erythematosus

Indexed keywords

HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HEMATURIA; HUMAN; INFLAMMATION; JOINT; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICIAN GLOBAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SAFETY OF ESTROGEN IN LUPUS ERYTHEMATOSUS NATIONAL ASSESSMENT; SENSITIVITY AND SPECIFICITY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH; VISUAL ANALOG SCALE;

DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; ESR; SYSTEMIC LUPUS ERYTHEMATOSUS;

BLOOD SEDIMENTATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; JOINTS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84879711769     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313492578     Document Type: Article

References (26)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999 ; 340: 448-454
2. Ballas SK. The erythrocyte sedimentation rate, rouleaux formation and hyperviscosity syndrome. Theory and fact. Am J Clin Pathol. 1975 ; 63: 45-48
3. Sox HC, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med. 1986 ; 104: 515-523
4. Reinhart WH, Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest. 1995 ; 25: 523-528
5. Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999 ; 60: 1443-1450
6. Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med. 1994 ; 51: 394-397
7. Gillum RF. A racial difference in erythrocyte sedimentation. J Natl Med Assoc. 1993 ; 85: 47-50
8. Bester FC, Weich DJ, Badenhorst PN, de Wet JI. Erythrocyte sedimentation rate in elderly blacks. S Afr Med J. 1993 ; 83: 498-500
9. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum. 1991 ; 21: 55-64
10. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 ; 32: 1107-1118
11. Petri M. Hopkins lupus cohort. 1999 update. Rheum Dis Clin North Am. 2000 ; 26: 199, 213, v - 199, 213, v
12. International council for standardization in haematology (expert panel on blood rheology). J Clin Pathol. 1993 ; 46: 198-203
13. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
15. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol. 1992 ; 19: 53-59
16. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
18. Yee CS, Farewell V, Isenberg DA, et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 2007 ; 56: 4113-4119
19. Vila LM, Alarcon GS, McGwin G, et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005 ; 32: 2150-2155
20. Nasiri S, Karimifar M, Bonakdar ZS, Salesi M. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group index in patients of rheumatology clinic. Rheumatol Int. 2010 ; 30: 1605-1609
21. Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford). 2000 ; 39: 1316-1319
22. Chang ER, Abrahamowicz M, Ferland D, Fortin PR. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity. J Rheumatol. 2002 ; 29: 2350-2358
23. Viallard JF, Bloch-Michel C, Neau-Cransac M, et al. HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol. 2001 ; 125: 485-491
24. Bauer JW, Petri M, Batliwalla FM, et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis Rheum. 2009 ; 60: 3098-3107
25. Samsonov MY, Tilz GP, Egorova O, et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus. 1995 ; 4: 29-32
26. Chiu YY, Nisihara RM, Wurzner R, Kirschfink M, de Messias-Reason IJ. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients. J Investig Allergol Clin Immunol. 1998 ; 8: 239-244